TSE

Takeda Selects Four New Partners for Annual Global Corporate Social Responsibility (CSR) Program to Help Strengthen Health Systems in Low- and Middle-Income Countries

Wednesday, September 22, 2021 - 2:30pm

Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (Takeda) today announced the addition of four partnerships to its Global Corporate Social Responsibility (CSR) Program , which makes long-term commitments to strengthen health systems and improve access to healthcare for all in developing and emerging countries.

Key Points: 
  • Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (Takeda) today announced the addition of four partnerships to its Global Corporate Social Responsibility (CSR) Program , which makes long-term commitments to strengthen health systems and improve access to healthcare for all in developing and emerging countries.
  • The project will strengthen access to equitable health services, build community resilience to climate shocks and help women forge their own path to a healthier future.
  • Each project addresses strengthening health systems in unique ways and aligns with countries national health needs.
  • In this release, Takeda is sometimes used for convenience where references are made to Takeda and its subsidiaries in general.

Five Strong Organizations Rebranded to form Teijin Automotive Technologies

Wednesday, September 22, 2021 - 3:30pm

Teijin Automotive Technologies, along with Teijin's automotive composites team in Japan, becomes industry-leading, global manufacturer of highly engineered products for automotive, heavy truck, marine and recreational vehicles

Key Points: 
  • Teijin Automotive Technologies, along with Teijin's automotive composites team in Japan, becomes industry-leading, global manufacturer of highly engineered products for automotive, heavy truck, marine and recreational vehicles
    AUBURN HILLS, Mich., Sept. 22, 2021 /PRNewswire/ --Fivestrong organizations Continental Structural Plastics (CSP), Inapal Plsticos, Benet Automotive, CSP Victall and Teijin Automotive Center Europe (TACE) have come together under a single brand to form Teijin Automotive Technologies, a global leader in composite materials and solutions for the worldwide mobility industry.
  • Utilizing all the strengths from the previously separate companies, Teijin Automotive Technologies can provide unique solutions for the next generation of mobility.
  • Teijin Automotive Technologies' innovation awards include Automotive News PACE Awards, JEC Innovation Awards, multiple CAMX and SPE Innovation Awards, and the General Motors Supplier Innovation Award.
  • Headquartered in Auburn Hills, Mich., USA, Teijin Automotive Technologies has 29 operations in 8 countries and employs more than 5,000 people.

Renesas’s Expands RA MCU Family With New RA4 Entry-Line Group Offering Optimal Value With Balanced Low Power Performance And Feature Integration

Wednesday, September 22, 2021 - 1:00pm

The new 100-MHz RA4E1 Group has best-in-class power consumption balanced with high performance and optimized feature integration.

Key Points: 
  • The new 100-MHz RA4E1 Group has best-in-class power consumption balanced with high performance and optimized feature integration.
  • View the full release here: https://www.businesswire.com/news/home/20210922005283/en/
    RA4E1 Entry-line MCUs Provide Low Power Consumption and Optimized Features (Graphic: Business Wire)
    Renesas RA Family now boasts over 150 parts ranging from 48MHz to 200MHz.
  • The RA Family MCUs offer industry-leading power consumption specifications, a very wide range of communications options, and best-in-class security options, including Arm TrustZone technology.
  • The RA4E1 Group is ideal for cost-sensitive applications and other systems requiring an optimal combination of performance and low power consumption.

Astellas to Present Fezolinetant 12-Week Findings from Phase 3 SKYLIGHT 2™ Trial in Oral Session at The North American Menopause Society 2021 Annual Meeting

Wednesday, September 22, 2021 - 1:00pm

Serious TEAEs occurred in less than 2 percent of patients in the fezolinetant groups and there were no drug-related serious TEAEs.

Key Points: 
  • Serious TEAEs occurred in less than 2 percent of patients in the fezolinetant groups and there were no drug-related serious TEAEs.
  • Detailed safety results will be available following the completion of the fezolinetant Phase 3 program, which will also include the SKYLIGHT 1 and SKYLIGHT 4 studies.
  • The BRIGHT SKY pivotal trials, SKYLIGHT 1 ( NCT04003155 ) and SKYLIGHT 2 ( NCT04003142 ), enrolled 1,028 women with moderate to severe vasomotor symptoms (VMS).
  • SKYLIGHT 4 ( NCT04003389 ), also underway, is a 52-week double-blinded and placebo-controlled study designed to investigate long-term safety of fezolinetant.

Trinseo Announces Significant Quarterly Dividend Increase to $0.32 Per Share

Tuesday, September 21, 2021 - 9:23pm

Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics and latex binders, today announced that its Board of Directors authorized a dividend of $0.32 per share, an increase of four times the amount of the most recent dividend.

Key Points: 
  • Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics and latex binders, today announced that its Board of Directors authorized a dividend of $0.32 per share, an increase of four times the amount of the most recent dividend.
  • In December 2020, Trinseo announced a dividend reduction to enable rapid near-term deleveraging following the acquisition of the PMMA business.
  • The dividend will be a cash distribution payable on October 7, 2021, to shareholders of record as of the close of business on October 1, 2021.
  • Commenting on the Companys quarterly dividend increase, Frank Bozich, President and Chief Executive Officer of Trinseo, said, The dividend increase reflects the high level of confidence we have in our future business performance and cash generation.

Gol and Grupo Comporte Order 250 VA-X4 Zero Emissions Aircraft From Avolon

Tuesday, September 21, 2021 - 12:00pm

As part of the agreement, Gol and Grupo Comporte has committed to purchase or lease up to 250 VA-X4 eVTOL aircraft.

Key Points: 
  • As part of the agreement, Gol and Grupo Comporte has committed to purchase or lease up to 250 VA-X4 eVTOL aircraft.
  • They introduce the ultra-short-haul aircraft category to commercial aviation and will revolutionise air travel with VA-X4 zero emissions aircraft.
  • This announcement means Avolon already has commitments for over half of its order for 500 VA-X4 aircraft which was announced in June 2021.
  • Gol and Grupo Comporte both bring broad and diverse networks, along with proven track records in scaling multiple businesses, making them the ideal strategic partners for Avolon.

INX Limited partners with Japanese Financial Giant GMO Internet Group to bring NYDFS Regulated Stablecoins to Retail and Institutional Investors

Tuesday, September 21, 2021 - 9:01pm

GMO Trust is the New York-based, regulated stablecoin subsidiary of Japanese financial services and internet conglomerate, GMO Internet Group (GMO Group).

Key Points: 
  • GMO Trust is the New York-based, regulated stablecoin subsidiary of Japanese financial services and internet conglomerate, GMO Internet Group (GMO Group).
  • To expand GMO Group's cryptocurrency footprint, GMO Trust was established as a limited purpose trust company regulated in New York and launched GYEN and ZUSD.
  • "INX is proud to partner with GMO, a global financial services powerhouse that is issuing financial-grade stablecoins."
  • For more information on GMO Trust, please visit https://stablecoin.z.com
    INX Limited launched the first SEC-registered digital security initial public offering (IPO) for both retail and institutional investors.

Mirum Pharmaceuticals and Takeda Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan

Tuesday, September 21, 2021 - 1:00pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210921005502/en/
    Under the terms of the agreement, Takeda will be responsible for regulatory approval and commercialization of maralixibat in Japan.
  • We are excited for Takeda to engage in the development of maralixibat and collaborate in our effort to advance this potentially life-changing therapy.
  • This agreement reinforces Takedas commitment to developing highly differentiated medicines to improve the health and quality of life of patients.
  • Maralixibat is a novel, minimally absorbed, orally administered investigational drug being evaluated in several rare cholestatic liver diseases.

Renesas Accelerates Deep Learning Development for ADAS and Automated Driving Applications

Tuesday, September 21, 2021 - 1:00pm

To alleviate these headaches when it comes to deep learning for automotive systems, Renesas is reinventing the developer experience, offering this new single package, multi-OS software platform that is easy for customers to access, learn, use, and install, enabling customers to quick start their deep learning development.

Key Points: 
  • To alleviate these headaches when it comes to deep learning for automotive systems, Renesas is reinventing the developer experience, offering this new single package, multi-OS software platform that is easy for customers to access, learn, use, and install, enabling customers to quick start their deep learning development.
  • Automakers are increasingly turning to deep learning as they look for new ways to enable smart camera applications and automated driving systems for next-generation vehicles.
  • However, most deep learning solutions available today are built on consumer or server applications, which do not operate under the same stringent constraints for functional safety, real-time responsiveness, and low power consumption.
  • Renesas offers a special version of its e studio for the R-Car V series that focuses on the creation of high-performance, real-time computer vision applications for ADAS and automated driving.

GOL To Launch Network of 250 eVTOL Aircraft in Brazil

Tuesday, September 21, 2021 - 12:46pm

SÃO PAULO, Sept. 21, 2021 /PRNewswire/ -- GOL Linhas Aéreas Inteligentes S.A. (NYSE: GOL and B3: GOLL4), ("GOL" or "Company"), Brazil's largest airline, in conjunction with Grupo Comporte, an entity of its controlling shareholder, announce that they have signed a non-binding letter of intent with Avolon for the acquisition and/or lease of 250 electric vertical takeoff and landing (eVTOL) aircraft. Following aircraft certification and successful delivery of the aircraft, the Company expects to start operating a flight network in Brazil using eVTOL planes by mid-2025.

Key Points: 
  • In cargo transportation, GOLLOG delivers parcels to various regions in Brazil and abroad.
  • Headquartered in Ireland, with offices in the United States, Dubai, Singapore, Hong Kong and Shanghai, Avolon provides aircraft leasing and lease management services.
  • Avolon is the world's third largest aircraft leasing business with an owned, managed and committed fleet, as of 30 June 2021 of 837 aircraft.
  • Although GOL believes that the estimates and projections in these forward-looking statements are reasonable, they may prove materially incorrect and actual results may materially differ.